Stay updated on CABozantinib in NSCLC MET Clinical Trial

Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding notice and the prior Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T01:31:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a site-wide funding status notice and has a version update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:25:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated metadata labels: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0' tag. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were replaced.
    Difference
    0.2%
    Check dated 2026-01-27T20:04:04.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T13:28:20.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added the Locations section with new site codes (AV, BA, FI, FO, ME, MI, MO, PA, PD, PG, PI, PR, RE, RM, RO, Torino) and removed individual Location subsections; updated Revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-22T01:56:39.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed as part of a site version update. This change affects only revision metadata and does not alter any study details, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T15:55:19.000Z thumbnail image

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.